Cargando…
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
Autores principales: | Bowsher, Ronald R., Devanarayan, Viswanath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538034/ https://www.ncbi.nlm.nih.gov/pubmed/33025311 http://dx.doi.org/10.1208/s12248-020-00510-8 |
Ejemplares similares
-
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
por: Rowntree, Louise C, et al.
Publicado: (2021) -
Serological assays and host antibody detection in coronavirus-related disease diagnosis
por: Dowlatshahi, Sayeh, et al.
Publicado: (2021) -
Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: James, Joe, et al.
Publicado: (2021) -
Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain
por: Johnson, Derrick, et al.
Publicado: (2021) -
A serological assay to detect human SARS-CoV-2 antibodies
por: Mahallawi, Waleed H.
Publicado: (2020)